WASHINGTON — The Food and Drug Administration has approved Arena Pharmaceutical’s anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade.
Utter confusion could result if the Supreme Court invalidates the Affordable Care Act’s (ACA) individual mandate while upholding other parts of the law, a physician expert predicted ahead of Thursday’s expected decision.